NCT00083057View on ClinicalTrials.gov

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions
Head and Neck Cancer
Interventions
DRUG

gefitinib

DRUG

paclitaxel

RADIATION

radiation therapy

Trial Locations (2)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

20892-1547

NCI - Metabolism Branch;MET, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00083057 - Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | Biotech Hunter | Biotech Hunter